Medicare Outpatient Prescription Drug Act of 2002
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Provides for: (1) part D benefits under Medicare+Choice plans under Medicare part C (Medicare+Choice); and (2) Medicare cost-sharing and other assistance for low-income individuals but only as it relates to benefits provided under new part D.
Revises Medicare supplemental insurance policy (Medigap) benefit packages to conform to changes made by this Act, eliminating obsolete policies with no grandfathering.
Directs the Secretary of Health and Human Services to study and report to Congress on the feasibility and advisability of: (1) establishing a uniform format for pharmacy benefit cards provided to beneficiaries; and (2) developing systems to transfer electronically prescriptions under such program from the prescriber to the pharmacist.
Requires the Comptroller General to conduct an ongoing study and analysis of the program established under this Act, especially: (1) the extent to which the competitive bidding process under it fosters maximum competition and efficiency; and (2) the savings to the Medicare program resulting from it, including the reduction in the number or length of hospital visits.
Expands the membership and duties of the Medicare Payment Advisory Commission (MEDPAC).
Sponsor introductory remarks on measure. (CR S5792)
- Introduced in Senate Formatted Text PDF
Cite this page
U.S. Congress. (2026). S. 2625: Medicare Outpatient Prescription Drug Act of 2002. 107th Congress. Open America. https://openamerica.io/bill/107-S-2625/
"S. 2625: Medicare Outpatient Prescription Drug Act of 2002." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-S-2625/.
S. 2625, 107th Cong. (2026), https://openamerica.io/bill/107-S-2625/.
[S. 2625: Medicare Outpatient Prescription Drug Act of 2002](https://openamerica.io/bill/107-S-2625/)